Negrini, Massimo
University of Ferrara,
Italy
2025 Rank: 88528
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3485 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 88528 | 97457 |
| Total Cites | 46332 | 50758 |
| H-index | 84 | 88 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 1506 | 1675 |
| Number of Single+First+Last Authored Papers | 91 | 91 |
| Total Cites to Single+First+Last Authored Papers | 6343 | 6872 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 31512 | 33144 |
| Ratio of Total Citations to Distinct Citing Papers | 1.47 | 1.53 |
| Self-Citation Percentage |
8.72%
|
|
Negrini, Massimo
University of Ferrara,
Italy
2024 Rank: 82815
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3326 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 82815 | 91400 |
| Total Cites | 44998 | 49305 |
| H-index | 82 | 87 |
| Hm-index | 20 | 20 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 1483 | 1647 |
| Number of Single+First+Last Authored Papers | 90 | 90 |
| Total Cites to Single+First+Last Authored Papers | 6157 | 6677 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 30457 | 32042 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.54 |
| Self-Citation Percentage |
8.74%
|
|
Negrini, Massimo
University of Ferrara,
Italy
2023 Rank: 78827
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3233 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78827 | 85898 |
| Total Cites | 43516 | 47748 |
| H-index | 81 | 85 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 1465 | 1627 |
| Number of Single+First+Last Authored Papers | 90 | 90 |
| Total Cites to Single+First+Last Authored Papers | 5928 | 6443 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 29280 | 30822 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.55 |
| Self-Citation Percentage |
8.86%
|
|
Negrini, Massimo
University of Ferrara,
Italy
2022 Rank: 72925
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3033 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 72925 | 79749 |
| Total Cites | 41428 | 45480 |
| H-index | 80 | 84 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 1416 | 1573 |
| Number of Single+First+Last Authored Papers | 85 | 85 |
| Total Cites to Single+First+Last Authored Papers | 5606 | 6091 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 27674 | 29152 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.56 |
| Self-Citation Percentage |
8.91%
|
|
Negrini, Massimo
University of Ferrara,
Italy
2021 Rank: 71767
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2995 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71767 | 77428 |
| Total Cites | 40303 | 44242 |
| H-index | 78 | 82 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 1391 | 1545 |
| Number of Single+First+Last Authored Papers | 85 | 85 |
| Total Cites to Single+First+Last Authored Papers | 5432 | 5897 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 26853 | 28289 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.56 |
| Self-Citation Percentage |
8.90%
|
|
Negrini, Massimo
University of Ferrara,
Italy
2020 Rank: 68155
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2987 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68155 | 73372 |
| Total Cites | 37538 | 41295 |
| H-index | 75 | 81 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 1335 | 1487 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 4967 | 5417 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 24660 | 25985 |
| Ratio of Total Citations to Distinct Citing Papers | 1.52 | 1.59 |
| Self-Citation Percentage |
9.10%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.